Clinical Trials Browser

OTHER × Clear-cell metastatic renal cell carcinoma × Sunitinib × Clear all

NCT02960906 2021-04-26

BIONIKK

Phase 2 Completed

Clear-cell metastatic renal cell carcinoma

NCT01499121 2018-03-06

Study of Efficacy and Safety of Sunitinib Given on an Individualized Schedule

Phase 2 Completed

Clear-cell metastatic renal cell carcinoma